Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic ma…
Biotechnology
US, Tarrytown [HQ]
REGN/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 379.00 | 459.00 | 445.00 | 1,378.00 | 2,104.00 | 2,819.00 | 4,103.00 | 4,860.00 | 5,872.00 | 6,710.00 | 7,863.00 | 8,497.00 | 16,071.00 | 12,172.00 | 13,117.00 | |
|
EPS
|
-0.85 | -1.26 | -2.45 | 7.92 | 4.23 | 3.36 | 6.17 | 8.55 | 11.27 | 21.29 | 19.38 | 32.65 | 76.40 | 40.51 | 37.05 | |
| Diluted in mil. | -0.85 | -1.26 | -2.45 | 6.75 | 3.72 | 2.98 | 5.52 | 7.70 | 10.34 | 21.29 | 18.46 | 30.52 | 71.97 | 38.22 | 34.77 | |
|
Profit
|
377.00 | 456.00 | 441.00 | 1,294.00 | 1,949.00 | 2,614.00 | 3,711.00 | 4,560.00 | 5,475.00 | 6,276.00 | 7,081.00 | 7,377.00 | 13,634.00 | 10,612.00 | 11,301.00 | |
| Gross Margin | 99.56 | 99.54 | 99.05 | 93.87 | 92.62 | 92.73 | 90.43 | 93.83 | 93.24 | 93.53 | 90.05 | 86.82 | 84.83 | 87.18 | 86.16 | |
| Pre Tax | -71.00 | -104.00 | -222.00 | 414.00 | 713.00 | 775.00 | 1,225.00 | 1,329.00 | 2,078.00 | 2,553.00 | 2,429.00 | 3,810.00 | 9,325.00 | 4,858.00 | 4,199.00 | |
| Profit Margin | -18.97 | -22.76 | -50.00 | 30.06 | 33.89 | 27.51 | 29.85 | 27.36 | 35.40 | 38.05 | 30.89 | 44.84 | 58.03 | 39.91 | 32.01 | |
| ETR | 5.73 | 2.03 | 0.51 | -81.04 | 40.51 | 55.13 | 48.08 | 32.66 | 42.34 | 4.27 | 12.90 | 7.80 | 13.41 | 10.71 | 5.85 | |
| Net | -67.00 | -104.00 | -221.00 | 750.00 | 424.00 | 348.00 | 636.00 | 895.00 | 1,198.00 | 2,444.00 | 2,115.00 | 3,513.00 | 8,075.00 | 4,338.00 | 3,953.00 | |
| Profit Margin | -17.88 | -22.76 | -49.74 | 54.43 | 20.16 | 12.34 | 15.50 | 18.42 | 20.41 | 36.42 | 26.91 | 41.35 | 50.25 | 35.64 | 30.14 | |
| EBITDA | -59.00 | -97.00 | -205.00 | 457.00 | 760.00 | 838.00 | 1,251.00 | 1,330.00 | 2,079.00 | 2,534.00 | 2,209.00 | 3,867.00 | 9,383.00 | 5,173.00 | 5,130.00 | |
| EBITDA Margin | -15.78 | -21.23 | -46.02 | 33.20 | 36.11 | 29.74 | 30.51 | 27.38 | 35.41 | 37.77 | 28.10 | 45.51 | 58.38 | 42.50 | 39.11 | |
| Operating Income | -74.00 | -97.00 | -205.00 | 457.00 | 760.00 | 838.00 | 1,251.00 | 1,330.00 | 2,079.00 | 2,534.00 | 2,209.00 | 3,576.00 | 8,946.00 | 4,738.00 | 4,047.00 | |
| Operating Margin | -19.54 | -21.23 | -46.02 | 33.20 | 36.11 | 29.74 | 30.51 | 27.38 | 35.41 | 37.77 | 28.10 | 42.09 | 55.67 | 38.93 | 30.85 | |
| Interest Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 30.00 | 18.00 | 45.00 | 160.00 | 495.00 | |
| Loss | -453.00 | -556.00 | -650.00 | -920.00 | -1,344.00 | -1,981.00 | -2,851.00 | -3,529.00 | -3,792.00 | -4,176.00 | -5,653.00 | -4,920.00 | -7,124.00 | -7,178.00 | -8,884.00 | |
| Cost of Revenue | -1.00 | -2.00 | -4.00 | -84.00 | -155.00 | -205.00 | -392.00 | -299.00 | -397.00 | -434.00 | -782.00 | -1,119.00 | -2,437.00 | -1,560.00 | -1,815.00 | |
|
Operating Expenses
|
-451.00 | -554.00 | -646.00 | -836.00 | -1,189.00 | -1,776.00 | -2,459.00 | -3,229.00 | -3,395.00 | -3,742.00 | -4,871.00 | -3,800.00 | -4,687.00 | -5,618.00 | -7,068.00 | |
| R&D | -398.00 | -489.00 | -529.00 | -625.00 | -859.00 | -1,271.00 | -1,620.00 | -2,052.00 | -2,075.00 | -2,186.00 | -3,036.00 | -2,735.00 | -2,908.00 | -3,592.00 | -4,439.00 | |
| G&A | -52.00 | -65.00 | -117.00 | -210.00 | -329.00 | -504.00 | -838.00 | -1,177.00 | -1,320.00 | -1,556.00 | - - | - - | - - | - - | - - | |
| SG&A | -52.00 | -65.00 | -117.00 | -210.00 | -329.00 | -504.00 | -838.00 | -1,177.00 | -1,320.00 | -1,556.00 | -1,834.00 | -1,346.00 | -1,824.00 | -2,115.00 | -2,631.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | -14.00 | -19.00 | -31.00 | -36.00 | -41.00 | -52.00 | -74.00 | -104.00 | -145.00 | -148.00 | -210.00 | -235.00 | -286.00 | -341.00 | -421.00 | |
| Interest Expenses | -2.00 | -9.00 | -21.00 | -45.00 | -46.00 | -37.00 | -14.00 | -7.00 | -25.00 | -28.00 | -30.00 | -56.00 | -57.00 | -59.00 | -73.00 | |
| Other Expenses | -4.00 | -2.00 | -3.00 | -2.00 | - - | -25.00 | -12.00 | - - | -1.00 | -19.00 | -219.00 | -233.00 | -379.00 | -119.00 | -456.00 | |
|
WA Shares Outstanding
|
79.00 | 82.00 | 90.00 | 111.00 | 111.00 | 113.00 | 115.00 | 116.00 | 115.00 | 114.00 | 109.00 | 107.00 | 105.00 | 107.00 | 106.00 | |
| Diluted | 79.00 | 82.00 | 90.00 | 115.00 | 111.00 | 113.00 | 115.00 | 116.00 | 115.00 | 114.00 | 114.00 | 115.00 | 112.00 | 113.00 | 113.00 |